Our results suggested that ILI has a stronger impact than the control program on concentrations of selected biomarkers that can characterize the atrial substrate and AF-related pathways, including inflammation (hsCRP), atrial stretch (NT-proBNP), and oxidative stress (3-NT). The gene discussed is NPPB; the disease is atrial fibrillation.